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Cryopreservation includes exposure of gametes to 
anti-freezing substances, cooling to subzero tem-
peratures, storing, melting, and ultimately, elimi-
nating the anti-freezing substance, when used, 
with a return to a physiological environment that 
will allow subsequent development. Sperm cryo-
preservation has been vastly used in sperm bank-
ing prior to chemotherapy or radiation treatment 
for cancer, donor sperm for couples without a male 
partner, and various etiologies of male factor 
infertility.1 Cryopreservation can prevent repeat-
ing surgical procedures used as cures for azoo-
spermic conditions like microsurgical epididymal 
sperm aspiration (MESA) and testicular sperm 
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Abstract
Reactive oxygen species (ROS) production and lipid peroxidation during cryopreservation harm sperm membrane 
and as a result reduce the recovery of motile sperm. The antioxidant effects of melatonin on different cells have 
been widely reported. This study was aimed to evaluate changes in post-thaw motility, viability, and intracellular ROS 
and malondialdehyde (MDA) in response to the addition of melatonin to human sperm freezing extender. Semen of 
43 fertile men was collected and each sample was divided into eight equal aliquots. An aliquot was analyzed freshly 
for viability, motility, and intracellular ROS and MDA. Melatonin was added to the recommended human freezing 
extender to yield six different final concentrations: 0.001, 0.005, 0.01, 0.05, 0.1, and 1 mM. A control group without 
melatonin was also included. Two weeks after cryopreservation, samples were thawed and pre-freeze analyses 
repeated. Obtained results showed that cryopreservation significantly (P <0.05) reduces viability and motility, but 
increases intracellular ROS and MDA of human sperm. The semen extender supplemented with various doses of 
melatonin (except for 0.001 mM) significantly (P <0.05) increased motility and viability, but decreased intracellular 
ROS and MDA levels of cryopreserved sperm after the thawing process, as compared with the control group. We also 
found that the most effective concentration of melatonin in protecting human spermatozoa from cryopreservation 
injuries was 0.01 mM. These findings suggest that melatonin exerts its cryoprotective effects on spermatozoa possibly 
by counteracting intracellular ROS, and thereby reduces MDA generation. This finally leads to increase of post-thaw 
viability and motility of cryopreserved spermatozoa.
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extraction (TESE). In addition, frozen semen per-
mits precise examination of the existence of infec-
tions such as HIV and HBS.2
Bunge and Sherman presented the first preg-
nancy resulting from the thawing of cryopreserved 
sperm in 1953.3 In spite of the considerable pro-
gress made in the sperm cryopreservation field, it 
is accompanied by some shortcomings. For exam-
ple, the motility and viability of sperm decrease 
significantly after the freezing and thawing pro-
cess. This is in part due to the fact that cryopreser-
vation induces oxidative stress and, as a result, the 
formation of reactive oxygen species (ROS). The 
polyunsaturated fatty acids of the sperm plasma 
membrane are susceptible to ROS damage inas-
much as its cytoplasm contains low concentrations 
of free radical scavenging enzymes.4 ROS start a 
chain of chemical reactions called lipid peroxida-
tion, which generates reactive metabolites, such as 
malondialdehyde (MDA). Lipid peroxidation 
reduces membrane fluidity and the activity of 
membrane enzymes and ion channels, resulting in 
the inhibition of normal cellular mechanisms 
required for sperm motility and fertility.5 A suita-
ble approach for the enhancement of cryopre-
served sperm is adding different substances such 
as antioxidants to the freezing solutions.6 
Antioxidants seem to be of great clinical impor-
tance by reducing the amount of free radicals and 
oxidative stress and, as a result, improving fertility 
potential in assisted reproductive technology 
(ART) techniques.7
Melatonin, thought to be the major output 
hormone of the pineal gland, plays important 
roles in the regulating of some physiological 
events. This molecule has the capability of 
removing and neutralizing free radicals such as 
hydroxyl, peroxyl, and peroxynitrite anions. In 
humans, it has been observed that melatonin 
relieves the sperm mitochondrial oxidative stress 
caused by ROS.8
In spite of the massive effort, due to the limita-
tion in human resources like collecting and pre-
serving samples, many aspects of the effect of 
antioxidants on maintaining the sperm parameters 
after freezing has remained vague and to some 
extent, unknown. For this reason, this study focused 
on examining the effect of melatonin antioxidant 
potential on the oxidative stress and human sperm 
parameters after freezing.
Materials and methods
Sample preparation
Semen samples were collected from 43 fertile men 
with sperm density more than 20 million per mL 
after 3–4 days of sexual abstinence in sterile plastic 
containers by masturbation in the privacy room adja-
cent to the laboratory. Ethical approval was obtained 
from the Ethics Committee of Ilam University of 
Medical Sciences. Informed consent was obtained 
from all donors. All subjects included in the study 
had no abnormalities during examination. To liquefy 
the clotted semen, samples were kept in a 37°C incu-
bator for 20–30 min. All samples were analyzed by a 
computer-assisted sperm analysis (CASA) system to 
quantify sperm count, motility parameters, and mor-
phometric features. According to the World Health 
Organization (WHO) criteria,9 sperm motility was 
divided into four classes: (1) class A or grade IV: 
Sperm with straight, progressive, and fast motility; 
(2) class B or grade III: Sperm with non-linear pro-
gressive, and slow motility; (3) class C or grade II: 
Sperm with non-progressive or rotational motility; 
and (4) class D or grade I: Sperm with any motility. 
After washing with washing medium (SAGE, USA), 
centrifuge (Hettich, 5000 g) was applied to separate 
the semen and sperm. The newly formed cell plaque 
was rewashed with the sperm washing medium and 
subsequently mixed with the cryopreservation solu-
tion (CS) drop by drop and slowly. Each sample was 
subdivided into eight equal parts: a part was exam-
ined fresh without being exposed to CS, another 
washed in CS devoid of melatonin (control group). 
Concentrations 0.001, 0.005, 0.01, 0.05, 0.1, and 
1 mM of melatonin were added into six remaining 
parts for freezing. The melatonin-treated samples 
and control group were kept for 10 min at room tem-
perature, 10 min in –20°C, 10 min in –70°C and 
finally transferred to a liquid nitrogen tank. After 2 
weeks, samples were taken out and thawed. This 
process consisted of keeping the newly extracted 
cryotubes at room temperature for 1–2 min and after-
wards in water bath in 37°C for 5 min. Samples were 
centrifuged at 300 x g, the supernatant was removed, 
and after adding sperm washing solution, the pre-
freeze analysis was repeated.
ROS assay
The determination of ROS was carried out using an 
ELISA kit (BlueGene Biotech Co. Ltd., PR China) 
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according to its manual instruction. In brief, sperm 
samples were washed three times in PBS. 
Afterwards, samples were resuspended in PBS and 
subjected to ultra-sonication three times. The sam-
ple was centrifuged at 1000 x g for 15 min at 2–8°C 
to remove cellular debris, and supernatant was 
used for the assay. Finally, ROS assay was per-
formed immediately. By plotting a standard curve, 
the concentration of ROS in each sample was 
determined. The results were expressed as µg of 
ROS/106 sperm.
MDA assay
The level of sperm MDA was determined through 
the thiobarbituric acid (TBA) reaction according to 
the method described by Rao et al.10 The MDA deter-
mination was carried out as follows: 250 µL of sperm 
lysate (as described above) sample, 50 µL of Butilate 
Hidroxitoluene (BHT, 50 mmol/L), and 750 µL of 
trichloric acetic acid (TCA 10 %) were incubated for 
10 min at 4°C and then centrifuged for 10 min at 
1000 rpm. In the next step, 750 µL of the supernatant 
were mixed with 750 µL of thiobar-bituric acid 5%. 
This mixture was heated for 15 min at 100°C, cooled 
and read at 532 nm. By plotting a standard curve, the 
concentration of MDA in each sample was deter-
mined. Values were expressed as pmol of MDA/106 
sperm.
Statistical analysis
All data were expressed as the mean ± Standard 
Deviation (SD) of three independent experiments. 
Statistical analyses were performed using SPSS 19 
(SPSS, Chicago, IL, USA). Comparisons among 
groups were performed with the one-way analysis 
of variance (ANOVA) test. If statistical signifi-
cance was found, the Tukey’s post-hoc test was 
performed. Values of P <0.05 were considered sta-
tistically significant.
Results
Sperm viability, motility, and ROS and lipid per-
oxidation (using MDA assay) levels of participants 
before cryopreservation are shown in Table 1.
Figure 1 shows the viability (%) in different 
groups of sperm after cryopreservation. The viabil-
ity significantly decreased in all melatonin-treated 
and untreated (control) sperm groups in compari-
son with the fresh sperms (P <0.05) after cryo-
preservation (Table 1 and Figure 1). However, 
the viability of sperm groups treated with the 
varying concentrations of melatonin significantly 
(P <0.05) increased (except for 0.001 mM mela-
tonin) with respect to the control group. After cryo-
preservation, the highest viability was observed for 
sperm group treated with 0.01 mM melatonin, 
which was about 1.6-fold of the control group.
Comparing Table 1 and Figure 2 indicated that 
the total motility significantly decreased in all mel-
atonin-treated and control groups in comparison 
with the fresh sperm (P <0.05) after cryopreserva-
tion. However, the motility of sperm groups treated 
with the varying concentrations of melatonin sig-
nificantly (P <0.05) increased (except for 0.001 
mM melatonin) with respect to the control group. 
After cryopreservation, the highest motility was 
observed for the sperm group treated with 0.01 
mM melatonin, which was about 1.75-fold of the 
control group.
To detect whether melatonin could reduce cryo-
preservation-induced ROS production, we deter-
mined ROS concentration in different groups of 
sperm which were treated with varying doses of 
melatonin. Comparing Table 1 and Figure 3 indi-
cated that the ROS concentration significantly 
decreased in all melatonin-treated and control groups 
in comparison with the fresh sperm (P <0.05) 
after cryopreservation. However, the ROS concen-
tration in sperm groups treated with the varying 
doses of melatonin significantly (P<0.05) 
increased (except for 0.001 mM melatonin) with 
respect to the control group. After cryopreserva-
tion, the lowest ROS concentration was observed 
Table 1. Fresh semen analysis of the study subjects before 
cryopreservation.
Characteristics Mean ± SD
Age (years) 32.51 ± 4.13
Volume (mL) 4.38 ± 1.25
pH 7.55 ± 0.22
Viability (%) 82 ± 12.97
Sperm concentration (106/mL) 65.50 ± 22.90
Sperm with normal morphology (%) 50.73 ± 14.66
Sperm motility (%) Class A 43 ± 10.38
 Class B 20 ± 1.64
 Class C 12 ± 1.51
 Class D 25 ± 4.20
Sperm ROS (µg/106 sperm) 0.12 ± 0.02
Sperm MDA (pmol/106 sperm) 73 ± 11
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in the sperm group treated with 0.01 mM mela-
tonin, which was about 47% of the control group. 
The ROS concentrations in 0.005, 0.05, 0.1, and 
1 mM melatonin-treated sperm groups reduced to 
79%, 59%, 66%, and 68% of the control group, 
respectively.
Lipid peroxides are derived from the peroxida-
tion of polyunsaturated fatty acids, and the most 
abundant lipid peroxide is MDA. Therefore, the 
content of sperm lipid peroxidation was deter-
mined by measuring MDA.10 To investigate 
whether melatonin could reduce cryopreservation-
induced MDA production, we measured MDA 
concentration in melatonin-treated sperm groups. 
Comparing Table 1 and Figure 4 indicated that the 
MDA concentrations significantly increased in all 
melatonin-treated and control groups after cryo-
preservation, as compared with the fresh sperms 
(P <0.05). However, the MDA concentration in 
sperm groups treated with the varying doses of 
melatonin significantly (P <0.05) decreased 
(except for 0.001 mM melatonin) when compared 
with the control group. After cryopreservation, the 
lowest MDA concentration was observed in the 
sperm group treated with 0.01 mM melatonin, 
which was about 63% of the control group. The 
MDA concentrations in 0.005, 0.05, 0.1, and 
1 mM melatonin-treated sperm groups reduced to 
Figure 1. The effect of varying concentrations of melatonin on sperm viability (%) after cryopreservation. Data are expressed as 
mean ± SD of five different experiments. *P <0.05 vs. control and 0.001 mM melatonin-treated groups. #P <0.05 vs. 0.005 mM 
melatonin-treated group. ‡P <0.05 vs. 0.05 mM melatonin-treated group. †P <0.05 vs. 0.1 and 1 mM melatonin-treated groups.
Figure 2. The effect of varying concentrations of melatonin on sperm’s total motility (%) after cryopreservation. Data are expressed 
as mean ± SD of five different experiments. *P <0.05 vs. control and 0.001 mM melatonin-treated groups. #P <0.05 vs. 0.005 mM 
melatonin-treated group. ‡P <0.05 vs. 0.05 mM melatonin-treated group. †P <0.05 vs. 0.1 and 1 mM melatonin-treated groups.
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82%, 71%, 85%, and 86.5% of the control group, 
respectively.
Discussion
Cryopreservation can damage spermatozoa in dif-
ferent levels structures, such as acrosome mem-
branes or mitochondria, and finally reduce its 
fertilizing ability.11,12 Furthermore, a significant 
reduction in the level of spermatozoa antioxidants 
has been reported as one of the causes of the 
enhanced susceptibility of these cells to peroxida-
tive injuries after cryopreservation.13 For these rea-
sons, protective effects of different exogenous 
antioxidants on sperm quality and function after 
thawing has been explored.7,13–15 In recent years, 
Figure 3. The effect of varying concentrations of melatonin on sperm’s ROS concentration (µg/106 sperm) after cryopreservation. 
Data are expressed as mean ± SD of five different experiments. *P <0.05 vs. control and 0.001 mM melatonin-treated groups. 
#P <0.05 vs. 0.005 mM melatonin-treated group. ‡P <0.05 vs. 0.05 mM melatonin-treated group. †P <0.05 vs. 0.1 and 1 mM 
melatonin-treated groups.
Figure 4. The effect of varying concentrations of melatonin on sperm’s MDA concentration (pmol/106 sperm) after 
cryopreservation. Data are expressed as mean ± SD of five different experiments. *P <0.05 vs. control and 0.001 mM melatonin-
treated groups. #P <0.05 vs. 0.005 mM melatonin-treated group. ‡P <0.05 vs. 0.05 mM melatonin-treated group. †P <0.05 vs. 0.1 
and 1 mM melatonin-treated groups.
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reports about the beneficial effects of melatonin in 
protecting spermatozoa from different kinds of 
injury have emerged. Several studies reported 
that melatonin protected animal spermatozoa 
from adverse effects of peroxidative agents.16,17 
Melatonin directly neutralizes a high number of 
toxic free radicals.18 However, the possible role of 
melatonin in protecting spermatozoa against oxi-
dative stress has not been fully identified up to 
now. To our knowledge, this is the first report 
exploring the protective effect of several concen-
trations of melatonin during human semen cryo-
preservation. Our results showed that the addition 
of 0.01 mM melatonin to the human semen freez-
ing medium improves significantly spermatozoa 
viability, motility, intracellular ROS and MDA 
concentrations post thawing, and thereby fertiliz-
ing ability.
Our results generally showed that the addition of 
melatonin to the freezing media increases viability 
and motility of cryopreserved sperms. The efficient 
concentration of melatonin that maintained highest 
viability and motility after cryopreservation was 
observed to be 0.01 mM. To our knowledge, there 
is no report about the effect of melatonin on the 
viability and motility of cryopreserved human 
sperm. However, studies on ram and bull sperm 
demonstrated that semen cryopreservation with 
2 mM melatonin increases viability and motility of 
post-thawed sperm.18,19
One of the most important reasons for reduced 
sperm survival after the freezing-thawing process 
seems to be damage to the membrane system 
through lipid oxidation from increased levels of 
ROS.20 Several studies have revealed that melatonin 
can improve sperm function, possibly by scaveng-
ing of ROS, but the effect of melatonin on the ROS 
concentration of human sperm after cryopreserva-
tion has not previously been assessed.8,21,22 In 
accordance with several previous studies, the results 
of the present study showed that ROS concentration 
significantly increased in post-thawed sperm when 
compared with fresh sperm.20,23,24 It has been shown 
that the protective effect of melatonin on cryopreser-
vation injuries occurs in a dose-dependent man-
ner.18,25,26) Therefore, in the present study, different 
concentrations of melatonin (0.001–1 mM) in the 
freezing medium were assayed. We observed that 
the addition of melatonin (0.005–1 mM) to freezing 
media significantly reduces ROS generation after 
cryopreservation, and the lowest ROS concentration 
was observed in sperm group treated with 0.01 mM 
melatonin. To our knowledge, this finding has not 
previously been reported.
In the present study, MDA concentration, which 
is an index of ROS-induced lipid peroxidation, was 
measured in human sperm before and after cryo-
preservation and in the presence of several doses of 
melatonin. Our results indicated that MDA concen-
tration significantly increased (nearly 2.5-fold) in 
post-thawed sperms when compared with fresh 
sperm. This finding was in agreement with the 
findings of several previous studies.4,27,28
We also found that the MDA concentration sig-
nificantly decreased in sperm groups treated with 
0.005, 0.01, 0.05, 0.1, and 1 mM of melatonin 
when compared with the control group. The lowest 
MDA concentration was observed in the sperm 
group treated with 0.01 mM melatonin, which was 
about 63% of the control group. Despite an exten-
sive literature search, we did not find any related 
study that shows antioxidant effects of melatonin 
against cryopreservation-induced MDA generation 
in human sperm. However, a study by Ashrafi et al. 
showed that supplementation of the freezing media 
with 3 mM melatonin decreased MDA level in 
Holstein bulls.19
In addition, in their study, Gavella et al. showed 
that human sperm incubated in the presence of 
melatonin 6 mM exhibited a significant decrease 
in the rate of Iron/ascorbate-induced MDA gen-
eration.8 In addition, in a study conducted by 
Perumal et al. in 2013, it was found that a sperm 
group treated with 3 mM of melatonin had signifi-
cantly increased motility and viability in compar-
ison with those treated with 1, 2, and 4 mM 
melatonin and the control group.29 It has been 
demonstrated that melatonin, via its ROS scav-
enging activity, significantly stimulated and sup-
ported fertilization and early development of 
mouse embryo at concentration 10−6 to 10−4 M. It 
has also been reported by El-Raey that 0.1 mM of 
melatonin significantly decreased the rate of lipid 
peroxidation. On the other hand, it significantly 
enhanced post-thawing viability, motility, glu-
tathione reductase and superoxide dismutase 
activity, and finally total antioxidant capacity.30 
The differences between the results of these stud-
ies and our study may be related to the difference 
in source of sperm and methodology.
In conclusion, the addition of melatonin to human 
semen freezing extender can protect spermatozoa 
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from the adverse effects of cryopreservation, as evi-
denced by post-thaw viability, motility, intracellular 
ROS and MDA concentrations, with 0.01 mM being 
the most effective concentration. These findings sug-
gest that melatonin exerts its cryoprotective effects 
on spermatozoa possibly by counteracting intracel-
lular ROS, and thereby reduces MDA generation. 
This finally leads to an increase in post-thaw viabil-
ity and motility of cryopreserved spermatozoa.
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